Enquirer Consulting Group

Reachable Buyer Map

Prepared for Marnie Curbow, Lumicell · September 2026
Here is the map Bethany promised. A drug given before surgery plus a device used inside it means your buyer is not one person, it is a sequence of rooms inside a finite set of facilities, and almost every one of those facilities sits on a public register with an address attached. Below is who sits in each lane, who actually signs, and how each one moves. It maps the market around breast conserving surgery, not your operations, and there is nothing to buy at the end of it.
Acute care hospitals
Where most lumpectomies are performed and where the two committees that matter both sit. The surgeon wants it, perioperative services has to run it, pharmacy has to stock and administer an agent given hours before the case, and the finance office has to be satisfied on the outpatient side. Measured in quarters, and one hospital rarely buys alone.
Who signs: a breast surgeon or chief of surgery champions; the value analysis committee and the pharmacy and therapeutics committee both have to say yes; supply chain or the chief financial officer signs.
3,107
acute care hospitals on the federal hospital register, counted today; a further 1,382 critical access hospitals sit outside this figure and carry far less surgical volume
Accredited cancer programs
The hospitals where cancer surgery actually concentrates. Accreditation brings a cancer committee, a breast program leader and quality reporting that a margin conversation speaks straight to. This is the list to start from rather than the full hospital register, because the volume and the vocabulary are already there.
Who signs: the cancer program administrator and the breast program leader sponsor it; the hospital's committees above still hold the pen.
More than 1,500
accredited programs in the United States and Puerto Rico, per the accrediting college's published figure
Accredited breast centers
The tightest lane on this page: centers that have chosen to be measured on breast care specifically, with a named breast program director and a surgeon leader. Every one is on a public, searchable list by state, so this lane is a named account list rather than a market estimate. Slowest to open, most influential once open.
Who signs: the breast program director and the surgeon leader together; the host hospital's committees complete it.
No current public count
the accrediting body publishes the list, not a total; the last figure it put in print was about 650 centers nearly a decade ago, so the list is built by name rather than sized
Federally designated cancer centers
The reference lane. Academic, evidence led, and slow, with pharmacy and surgical oncology chairs who expect the published data before the demonstration. Few in number, but a yes here is what the accredited programs ask about next.
Who signs: the chief of breast surgical oncology or the surgery chair sponsors; the center's pharmacy and value committees decide; nine in ten sit inside a larger health system that holds the contract.
66
designated centers that treat patients, as of May 2026; 58 comprehensive and 8 clinical, with 8 laboratory centers left out because they do not operate
Health systems
The contract lane. One system agreement can cover many operating rooms, and the decision moves from a single hospital's committee to a system value analysis team with its own process and calendar. Fewer conversations, each one heavier, and the one that turns adoption into distribution.
Who signs: the system vice president of supply chain or a system value analysis committee; a system chief medical officer sponsors where a surgeon champion has already delivered a site.
639
health systems in the 2023 federal compendium, the most recent published edition
Ambulatory surgery centers
The fastest lane and the one with a wrinkle. Breast conserving surgery is moving outpatient, and at a physician owned center the person who tests it is often the person who buys it. The wrinkle is the agent: a center needs a pharmacy pathway to receive and administer it hours before the case, and its payment rules differ from a hospital outpatient department.
Who signs: the administrator or the physician owner at single site centers; a chief clinical officer or supply chain lead where a management company runs several.
5,711
centers in the federal quality reporting program, counted today; the full population including centers outside that program is larger, so treat this as a floor
Breast surgeons
Not a buyer, the champion. No facility on this page adopts without a surgeon asking for it, and the surgeon society's membership is the nearest thing to a census of who does the asking. Reachable individually, and the single fastest way into any lane above.
Who signs: nobody here; the surgeon sponsors, then the facility's committees carry it.
About 4,000
members of the national breast surgeon society, treated as a ceiling because membership includes allied clinicians and members outside the United States
Breast imaging facilities
Upstream, not a buyer. Every lumpectomy begins at a mammogram, and the certified imaging facility is where the diagnosis and the surgical referral happen. Worth mapping because the radiologist and the navigator shape which surgeon and which facility the patient reaches.
Who signs: nobody; the breast imaging director and the nurse navigator influence the referral path.
9,042
certified mammography facilities on the federal register, as of October 2025

Where the openings are

1
Two committees, not one. A device goes through value analysis. A drug given before the case goes through pharmacy and therapeutics. Most surgical technology only has to win the first room, and most commercial teams are built for that room alone. Giving pharmacy its own story, its own evidence and its own contact is the cheapest improvement on this page.
2
The surgeon says yes, the system signs. Adoption starts with one surgeon at one site; scale comes when the system that owns that site puts it on contract. Working those as two separate motions, the champion first and the system agreement deliberately second, is what turns one hospital into many operating rooms.
3
Outpatient is where the volume and the payment already sit. Lumpectomy is an outpatient case, the hospital outpatient payment path for the agent is public and in place, and the surgery center lane below it is growing. That means the finance office can be met with an answer rather than a question, which is rare for a new surgical technology.
4
Everything above is a finite list. Accredited breast centers, accredited cancer programs, designated centers and health systems are all named in public, and the hospitals and surgery centers are enumerated in federal files with an address. The account list can be built in full and worked to the end, rather than sampled and guessed at, which is the difference between a pipeline you refill and a market you finish.
Built from the federal registers of hospitals, ambulatory surgery centers and certified mammography facilities, counted on 15 September 2026, together with the published figures of the surgeons' accrediting college, the national cancer institute's center list and the 2023 federal compendium of health systems. Counts are register and program anchors rather than market censuses, they are banded deliberately, the surgery center figure is stated as a floor, the surgeon figure as a ceiling, and the one lane with no credible current number says so rather than showing one.
ENQUIRER CONSULTING GROUP
enquirerconsulting.com